PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-46.92%
Negative net income growth while CSIQ stands at 158.41%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
3.62%
D&A growth of 3.62% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
389.61%
Deferred tax of 389.61% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
12.25%
SBC growth of 12.25% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
174.27%
Well above CSIQ's 36.36% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
71.27%
AR growth of 71.27% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-67.00%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
127.39%
Growth well above CSIQ's 36.36%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
55.61%
Lower 'other non-cash' growth vs. CSIQ's 126.30%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
2691.15%
Operating cash flow growth above 1.5x CSIQ's 171.37%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
10.33%
Some CapEx rise while CSIQ is negative at -1.91%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
557.36%
Liquidation growth of 557.36% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-177.12%
We reduce yoy other investing while CSIQ is 33.39%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-55.83%
We reduce yoy invests while CSIQ stands at 4.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-104.09%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
23.20%
We have some buyback growth while CSIQ is negative at -13.16%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.